In turn, IFN-γ may also act directly on tumor cells, upregulating the expression of HLA class I and II, enhancing their recognition by CD8+ T cells through MHC class I processing and presentation of TSA and TAA [147,155,156]. The gene discussed is IFNG; the disease is neoplasm.